Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Yazawa

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of the American Academy of Dermatology|December 22, 1999
Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized sclerodermaK Yamane, H Ihn, M Kubo, et al.
Journal of the American Academy of Dermatology|December 22, 1999
Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosisN Yazawa, K Kikuchi, H Ihn, et al.
The British Journal of Dermatology|August 3, 2006
Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgarisN Asashima, M Fujimoto, R Watanabe, et al.
Archives of Dermatological Research|January 5, 2002
Anti-U1RNP antibodies in patients with localized scierodermaK Yamane, H Ihn, M Kubo, et al.
Rheumatology (Oxford, England)|November 8, 2002
Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung diseaseH Ihn, Y Asano, M Kubo, et al.
Rheumatology (Oxford, England)|November 21, 2000
Clinical and laboratory features of scleroderma patients with pulmonary hypertensionK Yamane, H Ihn, Y Asano, et al.
The Journal of Rheumatology|November 18, 1998
Autoantibodies against calpastatin in sera from patients with systemic sclerosisS Sato, M Hasegawa, T Nagaoka, et al.
Clinical and Experimental Immunology|August 12, 1999
Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosisH Ihn, K Yamane, N Yazawa, et al.
The Journal of Rheumatology|April 29, 1998
High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvementN Yazawa, M Fujimoto, K Kikuchi, et al.
The Journal of Rheumatology|April 1, 2000
Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the diseaseH Ihn, N Yazawa, M Kubo, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of the American Academy of Dermatology|December 22, 1999
Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized sclerodermaK Yamane, H Ihn, M Kubo, et al.
Journal of the American Academy of Dermatology|December 22, 1999
Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosisN Yazawa, K Kikuchi, H Ihn, et al.
The British Journal of Dermatology|August 3, 2006
Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgarisN Asashima, M Fujimoto, R Watanabe, et al.
Archives of Dermatological Research|January 5, 2002
Anti-U1RNP antibodies in patients with localized scierodermaK Yamane, H Ihn, M Kubo, et al.
Rheumatology (Oxford, England)|November 8, 2002
Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung diseaseH Ihn, Y Asano, M Kubo, et al.
Rheumatology (Oxford, England)|November 21, 2000
Clinical and laboratory features of scleroderma patients with pulmonary hypertensionK Yamane, H Ihn, Y Asano, et al.
The Journal of Rheumatology|November 18, 1998
Autoantibodies against calpastatin in sera from patients with systemic sclerosisS Sato, M Hasegawa, T Nagaoka, et al.
Clinical and Experimental Immunology|August 12, 1999
Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosisH Ihn, K Yamane, N Yazawa, et al.
The Journal of Rheumatology|April 29, 1998
High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvementN Yazawa, M Fujimoto, K Kikuchi, et al.
The Journal of Rheumatology|April 1, 2000
Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the diseaseH Ihn, N Yazawa, M Kubo, et al.
Pageof 4